Upcoming Live Events
Mon 12:00 PM EDT
Actionable next-generation sequencing panel-based biomarkers in breast cancer: exploring the value of identifying patients with PIK3CA, AKT1, and PTEN alterations
This live session will discuss the role of PIK3CA, AKT1, and PTEN genes and the importance of identifying actionable alterations within them in patients with advanced...
Tue 12:00 PM EDT
Diving deeper into the HER2 IHC spectrum: evolving viewpoints and an emerging digital landscape
Past Live Events
Wed 11:00 AM PDT
HER2 IHC testing in the wake of the 2023 HER2 Breast Guideline Update¹ - Clinical Value, Classification & Scoring and the impact of the ASCO-CAP 2023 HER2 Breast Testing Guideline Update
This comprehensive session aims to support pathologists with clinical training to better understand the spectrum of HER2 IHC expression for identifying breast cancer...
Wed 12:00 PM CDT
HER2-low (IHC 1+ or IHC 2+/ISH-) Is a New Classification of HER2 Expression in Breast Cancer
HER2 has been, and continues to be, a practice-changing biomarker for guiding treatment decisions in breast cancer. Recently, a treatment option became available for...
Tue 3:30 PM PDT
HER2-low assessment: Challenges, Potential Solutions, and Clinical impact
The goal of this symposium is to educate about the advances in metastatic breast cancer diagnosis and treatment implications.
Tue 5:30 PM CDT
Optimizing Biomarker Testing in Resectable and Metastatic NSCLC: A Multidisciplinary Approach
This program will illustrate key best practices and new developments for biomarker testing in the care of patients with resectable and metastatic non-small cell lung...
Tue 12:00 PM CDT
Digital Pathology in Routine Practice: From AI to Z-Stacking
This presentation will highlight the progress in histopathology, image acquisition and image analysis in the field with a special emphasis on high throughput whole...
Mon 3:30 PM PDT
Breast Cancer Biomarkers: Current and Future Testing Strategies to Optimize Disease Management
This program provides an overview of the benefits and challenges of testing for various molecular biomarkers in breast cancer from the perspective of the pathologist.
Mon 12:00 PM CDT
The Importance of Genomic Testing in Identifying Pathogenic Gene Fusions
Join us as we discuss the importance of the collaboration between pathology and medical oncology.
Mon 12:00 PM CDT
Direct Diagnosis: How partnership and integration can improve the lives of patients
This session will follow a patient’s journey from initial biopsy to a clean bill of health, highlighting how digital pathology and AI products like Paige Breast and...
Wed 11:00 AM PST
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Overview
This comprehensive short course aims to support pathologists with clinical training to better understand FRα biology and scoring of this novel IHC marker for EOC samples.
Thu 11:00 AM PDT
What Have COVID-19 Autopsies Taught Us? - A Complimentary Update from USCAP and Cleveland Clinic
This session will give listeners an introduction to the pathology of COVID-19, with an emphasis on the lung, which is the main target of this disease. The relationship...
Thu 11:00 AM PDT
Gynecologic pathology: evolving concepts, classics, caveats
This session will discuss a selected but diverse group of gynecologic tract cases, highlighting some commonly encountered diagnostic problems and concepts. An emphasis...